Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M. +30 more·2017·Movement Disorders

DOI 10.1002/mds.27115

Cited by (736)

Items 301–400 of 736

The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation
Ana María Jiménez‐Cebrián, Ricardo Vallejo, Marta Elena Losa‐Iglesias, Daniel López‐López, César Calvo‐Lobo, Patricia Palomo‐López, Carlos Romero Morales, Emmanuel Navarro‐Flores · 2021 · International Journal of Environmental Research and Public Health
REMOVED: Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin
Aruna Sharma, Dafin Fior Muresanu, Ala Nozari, José Vicente Lafuente, Seaab Sahib, Z. Ryan Tian, Anca Dana Buzoianu, Ranjana Patnaik, Lars Wiklund, Hari Shanker Sharma · 2020 · Progress in brain research
Genetic parkinsonisms and cancer: a systematic review and meta-analysis
Andrea Sturchio, A. Dwivedi, J. A. Vizcarra, Martina Chirra, Elizabeth G. Keeling, I. Mata, M. Kauffman, M. Pandey, G. Roviello, C. Comi et al. · 2020 · Reviews in the Neurosciences
Sudden unexpected death in Parkinson's disease: why is drinking water important?
F. S. Menezes-Rodrigues, Cristiane S. Scorza, A. Fiorini, A. Caricati-Neto, C. A. Scorza, J. Finsterer, F. Scorza · 2019 · Neurodegenerative Disease Management
Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review
Irene Katsaiti, John V. Nixon · 2018 · Journal of Parkinson s Disease
Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson’s disease models via PMK-1/p38 MAPK and SKN-1/Nrf2 signaling
Marcos Francisco, Roberto Ricardo Grau · 2025 · Scientific Reports
Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection
Prabesh Kanel, Giulia Carli, Robert Vangel, Stiven Roytman, Nicolaas Ida Bohnen · 2023 · Frontiers in Neuroscience
A top‐down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls
Cristina Contini, Laura Fadda, Greca Lai, Carla Masala, Alessandra Olianas, Massimo Castagnola, Irene Messana, Federica Iavarone, Alessandra Bizzarro, Carlo Masullo et al. · 2023 · PROTEOMICS
miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson’s Disease
Zhirong Wan, Madiha Rasheed, Yumeng Li, Qin Li, Peifu Wang, Jilai Li, Zixuan Chen, Jichen Du, Yulin Deng · 2023 · Molecular Neurobiology
Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity
Fillipe Mendes de Araújo, Annyta Fernandes Frota, Lívia Bacelar de Jesus, Lorena Cuenca‐Bermejo, Kariny Maria Silva Ferreira, Cleonice Creusa dos Santos, Érica Novaes Soares, Jéssica Teles-Souza, Flávia Santos Sanches, Ana Carla S. Costa et al. · 2023 · Neurotoxicity Research
Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol
Kirstin Hester, Ellen F. Kirrane, Timothy Anderson, Nichole Kulikowski, Jane Ellen Simmons, David M. Lehmann · 2022 · Environment International
Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson’s Disease
Fillipe Mendes De Araújo, Annyta Fernandes Frota, Lívia Bacelar de Jesus, Ticiane Caribe Macedo, Lorena Cuenca‐Bermejo, Consuelo Sanchez-Rodrigo, Kariny Maria Silva Ferreira, Juciele Valéria Ribeiro de Oliveira, Maria de Fatima Dias Costa, Juan Segura-Aguilar et al. · 2022 · Cellular and Molecular Neurobiology
Baroreflex function in Parkinson's disease: Insights from the modified-Oxford technique.
J. Sabino-Carvalho, Roberta A. Cartafina, G. M. Guimarães, P. Brandão, J. Lang, L. Vianna · 2020 · Journal of Neurophysiology
In vitro neuroprotective potential of Clivia miniata and Nerine humilis (Amaryllidaceae) in MPP+-induced neuronal toxicity in SH-SY5Y neuroblastoma cells
S. Omoruyi, Joshua Delport, T. Kangwa, Abobaker S. Ibrakaw, C. Cupido, O. Ekpo, A. Hussein · 2020
Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson’s disease A53T mouse model
Alicia Flores‐Cuadrado, Daniel Saiz‐Sánchez, Alicia Mohedano‐Moriano, Alino Martı́nez-Marcos, Isabel Úbeda‐Bañón · 2019 · Acta Neuropathologica Communications
Extended-Release Amantadine for Levodopa-Induced Dyskinesia
Khashayar Dashtipour, Ali R. Tafreshi, Rajesh Pahwa, Kelly E. Lyons · 2019 · Expert Review of Neurotherapeutics
From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson’s disease
Ruoxin Tu, Zhongyu Han, Hongbo Zhang, Xiaoye Jia, Tong Sun, Hanlin Liu, Jingxian Li, Mi Tang, Shun Wang · 2025 · Frontiers in Immunology
Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson’s disease and therapeutic approaches
Anupam Awasthi, Kousik Maparu, Shamsher Singh · 2025 · Inflammopharmacology
Harnessing Mirror Neurons: A New Frontier in Parkinson’s Disease Rehabilitation—A Scoping Review of the Literature
R. Tedeschi, D. Platano, D. Donati, F. Giorgi · 2024 · Journal of Clinical Medicine
Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms.
H. Mansour, A. Mohamed, M. Khattab, Aiman S. El-Khatib · 2023 · Food and Chemical Toxicology
An Upconversion Nanoplatform Based Multi-Effective Theatment for Parkinson's Disease
Bin Hu, H. Fang, Zhixin Huang, Wen-Jing Huang, Li Huang, Huijie Liu, Fanzhen Lv, Wei Huang, Xiaolei Wang · 2023 · Social Science Research Network
Neuroprotective Effects of Ecklonia cava in a Chronic Neuroinflammatory Disease Model
Seong-Lae Jo, Hyun Ju Yang, Kang Joo Jeong, Hye Won Lee, Eui‐Ju Hong · 2023 · Nutrients
Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease
InHyeok Chung, Han-A Park, Jun Kang, Heyyoung Kim, S. Hah, Juhee Lee, H. Kim, Won-Seok Choi, J. Chung, Min-Jeong Shin · 2022 · Scientific Reports
Evaluating Oculomotor Tests before and after Vestibular Rehabilitation in Patients with Parkinson’s Disease: A Pilot Pre‐Post Study
Amirabas Abasi, Reza Hoseinabadi, Parvin Raji, Joseph H. Friedman, Mohammad Reza Hadian · 2022 · Parkinson s Disease
Therapies for Genetic Forms of Parkinson’s Disease: Systematic Literature Review
Laura Over, Norbert Brüggemann, Katja Lohmann · 2021 · Journal of Neuromuscular Diseases
Can We Put Aside Microelectrode Recordings in Deep Brain Stimulation Surgery?
J. Pastor, L. Vega-Zelaya · 2020 · Brain Science
Les symptômes non-moteurs de la maladie de Parkinson de la physiopathologie au diagnostic précoce
Mickael Aubignat, Mélissa Tir, Pierre Christophe Krystkowiak · 2020 · La Revue de Médecine Interne
Comparison of Actions between L-DOPA and Different Dopamine Agonists in Striatal DA-Depleted Microcircuits In Vitro: Pre-Clinical Insights.
Esther Lara-González, Mariana Duhne, Fátima Ávila-Cascajares, S. Cruz, J. Bargas · 2019 · Neuroscience
Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease
Zachary D. Wallen, Hong-Lei Chen, Erin M. Hill-Burns, S. Factor, C. Zabetian, H. Payami · 2018 · Neurology: Genetics
External segment of the globus pallidus in health and disease: Its interactions with the striatum and subthalamic nucleus
Atsushi Nambu, Satomi Chiken · 2023 · Neurobiology of Disease
TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
Yongtao He, Jiayin Zhao, Hongtian Dong, Xiaoshuang Zhang, Yufei Duan, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Ping Huang · 2023 · Life Sciences
Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
Milo Jarno Basellini, Josine Marie Kothuis, Alessandro Comincini, Gianni Pezzoli, Graziella Cappelletti, Samanta Mazzetti · 2023 · Frontiers in Bioscience-Landmark
Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays
Alessandra Consonni, Martina Miglietti, Chiara Maria Giulia De Luca, Federico Angelo Cazzaniga, Arianna Ciullini, Ilaria Linda Dellarole, Giuseppe Bufano, Alessio Di Fonzo, Giorgio Giaccone, Fulvio Baggi et al. · 2022 · Brain Sciences
Neuropsychiatric Features, Health-Related Quality of Life, and Caregiver Burden in Parkinson's Disease
Atul Goel, Sunil K. Narayan, Ramkumar Sugumaran · 2022 · Annals of Indian Academy of Neurology
Striatal Neurons Partially Expressing a Dopaminergic Phenotype: Functional Significance and Regulation
D. Troshev, A. Bannikova, V. Blokhin, A. Kolacheva, T. Pronina, M. Ugrumov · 2022 · International Journal of Molecular Sciences
L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson’s Disease Models
M. Sisalli, Salvatore Della Notte, A. Secondo, C. Ventra, L. Annunziato, A. Scorziello · 2022 · Cells
A multiple-tissue-specific magnetic resonance imaging model for diagnosing Parkinson’s disease: a brain radiomics study
Xiao-Jun Guan, Tao Guo, Cheng Zhou, Ting Gao, Jing-Jing Wu, Victor Han, Steven Cao, Hongjiang Wei, Yuyao Zhang, Min Xuan et al. · 2022 · Neural Regeneration Research
Therapeutic Devices for Motor Symptoms in Parkinson’s Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials
Joji Fujikawa, Ryoma Morigaki, Nobuaki Yamamoto, Teruo Oda, Hiroshi Nakanishi, Yuishin Izumi, Yasushi Takagi · 2022 · Frontiers in Aging Neuroscience
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo
Anne Kristin Braczynski, Marc M. Sevenich, Ian Gering, Tatsiana Kupreichyk, Emil Dandanell Agerschou, Yannick Kronimus, Pardes Habib, Matthias Stoldt, Dieter Willbold, Jörg Bernhard Schulz et al. · 2022 · Biomolecules
The Story of Levodopa
KalyanB Bhattacharyya · 2022 · Annals of Indian Academy of Neurology
A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons
Éva M. Szegő, Éva M. Szegő, Fabian Boß, Daniel Komnig, Charlott Gärtner, Lennart Höfs, Hamed Shaykhalishahi, Michael WÃ¶rdehoff, Theodora Saridaki, Jörg B. Schulz et al. · 2021 · Frontiers in Neuroscience
The Four Square Step Test for Assessing Cognitively Demanding Dynamic Balance in Parkinson’s Disease Patients
Jinhee Kim, I. Kim, Y. Kim, S. Koh · 2021 · Journal of Movement Disorders
α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine
Jian-Mei Gao, Wen-Bo Li, Yi Yang, Jiajia Wei, Miaoxian Gong, Bin-Bin Pan, Xun-Cheng Su, Yu‐Chen Pan, Dong‐Sheng Guo, Qihai Gong · 2025 · Biomaterials
Parkinson's disease progression is shaped by longitudinal changes in cerebral compensation
Martin E. Johansson, I. Toni, B. Bloem, R. Helmich · 2025 · medRxiv
Impact of Particulate Matter 2.5 on Neurological Diseases: Insights Into Pathophysiological and Molecular Mechanisms
Carmen Rubio, Alejandro López-Landa, Norma Serrano‐García, Héctor Romo Parra, Moisés Rubio‐Osornio · 2025 · Journal of Toxicology
Fundamental neurochemistry review: Old brain stories ‐ Influence of age and sex on the neurodegeneration‐associated lipid changes
Lorena Cuenca‐Bermejo, Alessandro Prinetti, Karolina R. Kublickiene, Valeria Raparelli, Alexandra Kautzky‐Willer, Colleen M. Norris, Louise Pilote, María Trinidad Herrero · 2023 · Journal of Neurochemistry
Migratory Response of Cells in Neurogenic Niches to Neuronal Death: The Onset of Harmonic Repair?
Noelia Geribaldi-Doldán, Livia Carrascal, Patricia Pérez-García, J. M. Oliva-Montero, R. Pardillo-Díaz, Samuel Domínguez-García, C. Bernal-Utrera, Ricardo Gómez-Oliva, Sergio Martínez-Ortega, Cristina Verástegui et al. · 2023 · International Journal of Molecular Sciences
Deep Brain Stimulation for Advanced Parkinson Disease in Developing Countries: A Cost-Effectiveness Study From China
Xinxia Guo, Feng Chen, Jiali Pu, Hongjie Jiang, Zhoule Zhu, Zhe Zheng, Jianmin Zhang, Gao Chen, Junming Zhu, Hemmings Wu · 2022 · Neurosurgery
Transitions and challenges for people with Parkinson’s and their family members: A qualitative study
Joy Read, Rachael Frost, Kate R Walters, Remco Tuijt, Jill Manthorpe, Bev Maydon, Jennifer Pigott, Anette E. Schrag, Nathan Davies · 2022 · PLoS ONE
The Emerging Applications of Nanotechnology in Neuroimaging: A Comprehensive Review
Khunza Faiz, Fred C. Lam, Jay Chen, Ekkehard Matthias Kasper, Fateme Salehi · 2022 · Frontiers in Bioengineering and Biotechnology
Chapter 5 – “Parkinson's disease – A role of non-enzymatic posttranslational modifications in disease onset and progression?”
Sebastian W. Schmidt, Daniela M. Vogt Weisenhorn, Wolfgang Wurst · 2022 · Molecular Aspects of Medicine
Autoimmune Disease Associated CLEC16A Variants Convey Risk of Parkinson’s Disease in Han Chinese
Hui-Hui Fan, Lei Cui, Xiao-Xia Jiang, Ya-Dan Song, Shu-Shu Liu, Ke-Yun Wu, Haojia Dong, Miao Mao, Begench Ovlyakulov, Hongmei Wu et al. · 2022 · Frontiers in Genetics
Cortical excitability changes as a marker of cognitive impairment in Parkinson’s disease
Nitish Kamble, Amitabh Bhattacharya, Shantala Hegde, N. Vidya, Mohit Gothwal, Ravi Yadav, Pramod Kumar Pal · 2022 · Behavioural Brain Research
Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey
Mayuko Ogawa, Genko Oyama, Satoko Sekimoto, Taku Hatano, Nobutaka Hattori · 2021 · Journal of Movement Disorders
Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease
Marcello Serra, Annalisa Pinna, Giulia Costa, Alessandro Usiello, Massimo Pasqualetti, Luigi Avallone, Micaela Morelli, Francesco Napolitano · 2021 · International Journal of Molecular Sciences
Informed Consent Decision-Making in Deep Brain Stimulation
Gabriele Mandarelli, Germana Moretti, Massimo Pasquini, Giuseppe Nicolò, Stefano Ferracuti · 2018 · Brain Sciences
Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques
Mallory J. Stenslik, April Evans, François Pomerleau, Ryan M. Weeks, Peter F. Huettl, E. Foreman, Jadwiga T. Turchan-Cholewo, Anders H. Andersen, Wayne A. Cass, Z. Zhang et al. · 2018 · Journal of Neuroscience Methods
Changing views after 200 years of Parkinson disease
Walter Maetzler, Daniela Berg · 2018 · Nature Reviews Neurology
Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
Ankur Butala, Melissa D. Shepard, Gregory M. Pontone · 2019 · Handbook of clinical neurology
Oral health implications in Parkinson’s disease
Xiaohui Qiu, Ran Zhang, Yi Cheng, Chengde Jin, Yushi Zhang, Ziqi Zhang · 2025 · npj Parkinson s Disease
Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer’s Disease
Sakthi Priyadarshini, Keshav Goyal, R Roopashree, Saurabh K. Gupta, Aatreyi Roy, Ritabrata Biswas, Sandeep Patra, Payal Chauhan, Karan Wadhwa, Govind Singh et al. · 2025 · Molecular Neurobiology
Mitochondrial Dysfunction in Parkinson’s Disease: A Contribution to Cognitive Impairment?
Antonella Scorziello, Rossana Sirabella, Maria Josè Sisalli, Michele Tufano, Lucia Giaccio, Elena D’Apolito, Lorenzo Castellano, Lucio Annunziato · 2024 · International Journal of Molecular Sciences
Construct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models
Rayanne Poletti Guimarães, Maria Clara Souza de Resende, Miguel Mesquita Tavares, Caio Vinícius Ibias Belardinelli de Azevedo, Miguel Cesar Merino Ruiz, Márcia Renata Mortari · 2024 · International Journal of Molecular Sciences
Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson’s disease
Begench Ovlyakulov, Beilei Hu, Hong-Yang Kan, Qing Guo, Xiaofen Li, Hui-Hui Fan, Hongmei Wu, Jianyong Wang, Xiong Zhang, Jian‐Hong Zhu · 2024 · International Immunopharmacology
Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease
Qiaoying Huang, Congmin Chen, Weizhao Chen, Chaoyu Cai, Hailin Xing, Junyu Li, Mingtao Li, Shanshan Ma · 2023 · Neurobiology of Disease
Mobile Applications for Resting Tremor Assessment in Parkinson’s Disease: A Systematic Review
Paloma Moreta-de-Esteban, P. Martín-Casas, R. Ortiz-Gutiérrez, S. Straudi, R. Cano-de-la-Cuerda · 2023 · Journal of Clinical Medicine
Cognitive and Functional Trajectories in Older Adults With Prediagnostic Parkinson Disease
Meredith Bock, Eric Vittinghoff, Amber L. Bahorik, Yue Leng, Howard A Fink, Kristine S. Yaffe · 2022 · Neurology
Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
I. Buard, Natalie Lopez-Esquibel, Finnuella J. Carey, Mark S. Brown, Luis D. Medina, E. Kronberg, C. S. Martin, Sarah E Rogers, S. Holden, Michael R. Greher et al. · 2022 · Frontiers in Human Neuroscience
Dietary Inflammatory Index score and prodromal Parkinson's disease incidence: The HELIAD study
Vasileios Balomenos, Lamprini Bounou, Sokratis Charisis, María Stamelou, Eva Ntanasi, Kyriaki Georgiadi, Ioannis Mourtzinos, Katerina Tzima, Costas Anastasios Anastasiou, Georgia Xiromerisiou et al. · 2022 · The Journal of Nutritional Biochemistry
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, Lina Guan, Genmeng Yang, Liu Liu, Jian An Huang, Yuanyuan Li, Shijun Hong, Lihua Li · 2022 · Psychopharmacology
Assessing the Effects of Vitamin D on Neural Network Function in Patients With Parkinson’s Disease by Measuring the Fraction Amplitude of Low-Frequency Fluctuation
L. Lv, Hai-Nan Zhang, X. Tan, Lixia Qin, Xinke Peng, R. Bai, Q. Xiao, Chang-Lian Tan, Hai-Yan Liao, Wei-qian Yan et al. · 2021 · Frontiers in Aging Neuroscience
Predicting Parkinson’s Disease and Its Pathology via Simple Clinical Variables
İbrahi̇m Karabayir, Liam Butler, Samuel M. Goldman, Rishikesan Kamaleswaran, Fatma Güntürkün, Robert L. Davis, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Caroline M. Tanner et al. · 2021 · Journal of Parkinson s Disease
Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with parkinson’s disease: a Meta-analysis of randomized controlled trials
Peikun He, Li Min Wang, Jia Ning Chen, Yu Hu Zhang, Yu Gao, Qi Huan Xu, Yi Hui Qiu, Hui Cai, You Li, Zhi Huang et al. · 2020 · International Journal of Neuroscience
REMOVED: Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson's disease exacerbated by concussive head injury
Feng Niu, Aruna Sharma, Zhenguo Wang, Lianyuan Feng, Dafin Fior Muresanu, Seaab Sahib, Z. Ryan Tian, José Vicente Lafuente, Anca Dana Buzoianu, Ala Nozari et al. · 2020 · Progress in brain research
Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort
Chunyu Li, Yongping Chen, Ruwei Ou, Xiaojing Gu, Qianqian Wei, Bei Cao, Lingyu Zhang, Yanbing Hou, Kuncheng Liu, Xueping Chen et al. · 2020 · Neurobiology of Aging
Macular Abnormalities Associated With 5α-Reductase Inhibitor.
Yong Kyun Shin, Geun Woo Lee, Se-Woong Kang, Sang Jin Kim, A. Kim · 2020 · JAMA ophthalmology
EEG coherence as a diagnostic tool to measure the initial stages of Parkinson Disease
Mariana Gongora, Bruna Velasques, Maurício Cagy, Silmar Silva Teixeira, Pedro F. M. Ribeiro · 2018 · Medical Hypotheses
Exogenous Tetranectin Protects Against 1-Methyl-4-Phenylpyridine-Induced Neurotoxicity by Inhibiting Apoptosis and Autophagy Through Ribosomal Protein S6 Kinase Beta-1.
Qiang Xie, Meng Liu, Yu-Feng Yan, Xiao Shen, E.-S. Wang · 2019 · World Neurosurgery
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy
Xiao Ding, Luigi Piero Stasi, Xuedong Dai, Kai Long, Cheng Peng, Baowei Zhao, Hailong Wang, Changhui Sun, Huan Hu, Zehong Wan et al. · 2018 · Bioorganic & Medicinal Chemistry Letters
Autonomic dysfunction in Parkinson’s disease and other synucleinopathies: introduction to the series
J. Palma · 2018 · Movement Disorders
Unrevealing the molecular mechanisms of MPTP-induced Parkinson’s in experimental animals
Somnath Mondal, Sayeed Mohammed Firdous · 2025 · Medicinal Chemistry Research
Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson’s disease: a prospective observational study
Hongyan Yi, Xiaojing Liang, Fugui Xu, Tiantian Li, Xiu Yang, Ming Wei, Zhou Ou, Lijun Wang, Qiang Tong · 2024 · BMC Neurology
Citrobacter rodentium infection impairs dopamine metabolism and exacerbates the pathology of Parkinson’s disease in mice
Yongtao He, Jiayin Zhao, Yuanyuan Ma, Xin Yan, Yufei Duan, Xiaoshuang Zhang, Hongtian Dong, Rong Fang, Yunhe Zhang, Qing Li et al. · 2024 · Journal of Neuroinflammation
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills
Giuseppe Rabini, Claudia Meli, Giulia Prodomi, Chiara Speranza, Federica Anzini, Giulia Funghi, Enrica Pierotti, Francesca Saviola, Giorgio Fumagalli, Raffaella Di Giacopo et al. · 2024 · Scientific Reports
Human Embryonic Stem Cell-Derived Immature Midbrain Dopaminergic Neurons Transplanted in Parkinsonian Monkeys
Adolfo López-Ornelas, Itzel Escobedo-Ávila, Gabriel Ramirez‐Garcia, Rolando Lara-Rodarte, César Meléndez-Ramírez, Beetsi Urrieta-Chávez, Tonatiuh Barrios‐García, Verónica Alejandra Cáceres-Chávez, Xóchitl Flores-Ponce, Francia Carmona et al. · 2023 · Cells
Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson’s disease subtypes
Abigail E. Bower, Sophia J. Crisomia, Jae Woo Chung, Justin P. Martello, Roxana Gabriela Burciu · 2023 · Frontiers in Neurology
Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis
Yunan Zhou, Zhihui Li, Chunling Chi, Chunmei Li, Meimei Yang, Bin Liu · 2023 · Parkinson s Disease
Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson’s disease
A. Slézia, P. Hegedüs, E. Rusina, Katalin Lengyel, N. Solari, A. Kaszás, D. Balázsfi, Boris Botzanowski, E. Acerbo, F. Missey et al. · 2023 · bioRxiv
A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity In Vivo
Anastasiia Kotliarova, A. Podturkina, A. Pavlova, Daria S. Gorina, A. Lastovka, O. Ardashov, A. Rogachev, A. Izyurov, A. Arefieva, Alexander V. Kulikov et al. · 2022 · Molecules
Who to Enroll in Parkinson Disease Prevention Trials?
Samantha A. Molsberry, Katherine C. Hughes, Michael A. Schwarzschild, Alberto Ascherio · 2022 · Neurology
Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease
Björn H. Falkenburger, Theodoros Kalliakoudas, H. Reichmann · 2022 · Journal of neural transmission
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen · 2022 · European Journal of Inflammation
Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies
Lisanne J. Dommershuijsen, Agnita J.W. Boon, M. Kamran Ikram · 2021 · Frontiers in Neurology
Animal Models of Autosomal Recessive Parkinsonism
Guendalina Bastioli, Maria Regoni, Federico Angelo Cazzaniga, Chiara Maria Giulia De Luca, Edoardo Bistaffa, Letizia Zanetti, Fabio Moda, Flavia Valtorta, Jenny Sassone · 2021 · Biomedicines
The Role of TMEM230 Gene in Parkinson’s Disease
H. Deng, Kuan Fan, J. Jankovic · 2018 · Journal of Parkinson's Disease
Parkinson’s Disease–An Introduction
Chandra Shekhar Rawat, Sanjay Pandey · 2021 · Series in bioengineering
The autoimmune response induced by α-synuclein peptides drives neuronal cell death and glial cell activation
Yong‐Ho Choe, Min Gi Jo, Bo Gyu Kim, Sangwon Lee, Bina Lee, Seon‐Hee Kim, Hyemin Seong, Woong-Sun Yoo, Minkyeong Kim, Dong‐Kun Lee et al. · 2024 · Journal of Autoimmunity
New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
Lorena Ortega Moreno, Ana Bagüés, Vicente Martı́nez, Raquel Abalo · 2023 · Nutrients
Diagnostic Uncertainties in Tremor
Luca Marsili, Matteo Bologna, Abhimanyu Mahajan · 2023 · Seminars in Neurology
Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis
Lili He, Hecong Zhao, Fuli Wang, Xiaoyan Guo · 2022 · Frontiers in Neurology